Trial Information

Summary: Clinical trial to test an experimental study drug in people with Moderate to Severe Chronic Plaque Psoriasis

The purpose of this study is to gauge the safety and effectiveness of an experimental drug in people with moderate to severe chronic plaque psoriasis. Two different doses will be studied and compared to placebo.

To qualify, you must:

  • Be at least 18 years of age

You will not qualify if you:

  • Are pregnant or breast-feeding
  • Have participated in a research study within the past 30 days.

Contact:

Elizabeth Camacho, Research Coordinator
Biomedical Research Alliance of New York
NYU School of Medicine
Department of Dermatology
560 First Ave. - H - 158
New York, NY 10016
Telephone: 212-263-5244
Email:

Profile Page: Biomedical Research Alliance of New York, New York, NY

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:36:37 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA